D5LR VS PLR

Lactated RingersGeneric Name: sodium chloride, sodium lactate, potassium chloride, and calcium chlorideDosage Form: injection, solutionAds by Google

Compounding Supply Depotserum-vials.com/wholesale.htmSerum vial packaging and filtration Discount prices worldwide delivery!

China's Best Manufacturerwww.taflon.comof Energy Saving and High Quality of Sodium Chlorate Electrolyzer

Serum Vial Packagingwww.vgdusa.comSerum Vials Seals Stoppers Crimpers Worldwide shipping - huge selection

LACTATED RINGER’S IRRIGATION

FOR ALL GENERAL IRRIGATION, WASHING AND RINSING PURPOSES

Not For Injection By Usual Parenteral Routes

Flexible Irrigation Container

Rx Only

Lactated Ringers Description

Lactated Ringer’s Irrigation is a sterile, nonpyrogenic solution of electrolytes in water for injection intended only for sterile irrigation, washing and rinsing purposes. The composition is based on a modification of the injectable formula originally known as Hartmann’s Solution.

Each 100 mL of Lactated Ringer’s Irrigation contains: Sodium chloride 600 mg; sodium lactate, anhydrous 310 mg; potassium chloride 30 mg; calcium chloride, dihydrate 20 mg. The pH is 6.6 (6.0 — 7.5). The solution is isotonic (274 mOsmol/liter, calc.) and has the following electrolyte content (mEq/liter): Sodium (Na+) 130; potassium (K+) 4; calcium (Ca++) 3; chloride (Cl−) 109 and lactate (CH3CH(OH)COO−) 28. Contains sodium hydroxide and may contain hydrochloric acid for pH adjustment.

The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only for use as a single-dose or short procedure irrigation. When smaller volumes are required, the unused portion should be discarded. Lactated Ringer’s Irrigation may be classified as a sterile irrigant, wash, rinse and pharmaceutical vehicle.

Calcium Chloride, USP is chemically designated calcium chloride, dihydrate (CaCl2 • 2H2O), white fragments or granules freely soluble in water.

Potassium Chloride, USP is chemically designated KCl, a white granular powder freely soluble in water.

Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water.

Sodium Lactate, USP is chemically designated C3H5NaO3, a 60% aqueous solution miscible in water. It has the following structural formula:

Water for Injection, USP is chemically designated H2O.

The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions inside the plastic container also can leach out certain of its chemical components in very small amounts before the expiration period is attained. However, the safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers.

Lactated Ringers - Clinical Pharmacology

Lactated Ringer’s Irrigation exerts a mechanical cleansing action for sterile irrigation of body cavities, tissues or wounds, indwelling urethral catheters and surgical drainage tubes, and for washing, rinsing or soaking surgical dressings, instruments and laboratory specimens. It also serves as a vehicle for drugs used for irrigation or other pharmaceutical preparations.

Lactated Ringer’s Irrigation provides an isotonic irrigation with the same ionic constituents as Lactated Ringer’s Injection, USP, a modification of Hartmann’s Solution.

Lactated Ringer’s Irrigation is considered generally compatible with living tissues and organs.

Calcium chloride in water dissociates to provide calcium (Ca++) and chloride (Cl−) ions. They are normal constituents of the body fluids and are dependent on various physiologic mechanisms

for maintenance of balance between intake and output. Approximately 80% of body calcium is excreted in the feces as insoluble salts; urinary excretion accounts for the remaining 20%.

Potassium chloride in water dissociates to provide potassium (K+) and chloride (Cl−) ions. Potassium is the chief cation of body cells (160 mEq/liter of intracellular water). It is found in low concentration in plasma and extracellular fluids (3.5 to 5.0 mEq/liter in a healthy adult). Potassium plays an important role in electrolyte balance.

Normally about 80 to 90% of the potassium intake is excreted in the urine; the remainder in the stools and to a small extent, in the perspiration. The kidney does not conserve potassium well so that during fasting or in patients on a potassium-free diet, potassium loss from the body continues resulting in potassium depletion.

Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl−) ions. Sodium (Na+) is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Chloride (Cl−) has an integral role in buffering action when oxygen and carbon dioxide exchange occurs in the red blood cells. The distribution and excretion of sodium (Na+) and chloride (Cl−) are largely under the control of the kidney which maintains a balance between intake and output.

Sodium lactate in water dissociates to provide sodium (Na+) and lactate (C3H5O3–) ions. The lactate anion provides an alkalizing effect resulting from simultaneous removal by the liver of lactate and hydrogen ions. In the liver, the lactate is metabolized to glycogen which is ultimately converted to carbon dioxide and water by oxidative metabolism.

The lactate anion acts as a source (alternate) of bicarbonate when normal production and utilization of lactic acid is not impaired as a result of disordered lactate metabolism. Since metabolic conversion is dependent on the integrity of cellular oxidative processes, lactate may be inadequate or ineffective as a source of bicarbonate in patients suffering from acidosis associated with shock or other disorders involving reduced perfusion of body tissues. When oxidative activity is intact, one to two hours time is required for metabolism of lactate.

Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).

Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.

Ads by Google

Quality DSSC ElectrolytesIoLiTec supplies high quality DSSC electrolytes and custom formulationwww.iolitec.de

Serum Vial PackagingSerum Vials Seals Stoppers Crimpers Worldwide shipping - huge selectionwww.vgdusa.com

Transflux tmThe NEW STANDARD in contrast administration!www.prmedical.be

Indications and Usage for Lactated Ringers

Lactated Ringer’s Irrigation is indicated for all general irrigation, washing and rinsing purposes which permit use of a sterile, nonpyrogenic electrolyte solution.

Contraindications

NOT FOR INJECTION BY USUAL PARENTERAL ROUTES.

An electrolyte solution should not be used for irrigation during electrosurgical procedures.

Warnings

FOR IRRIGATION ONLY. NOT FOR INJECTION.

Irrigating fluids have been demonstrated to enter the systemic circulation in relatively large volumes; thus this irrigation must be regarded as a systemic drug. Absorption of large amounts can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.

The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.

Do not heat container over 66°C (150°F).

Precautions

Do not use for irrigation that may result in absorption into the blood.

Caution should be observed when the solution is used for continuous irrigation or allowed to “dwell” inside body cavities because of possible absorption into the blood stream and the production of circulatory overload.

Aseptic technique is essential with the use of sterile solutions for irrigation of body cavities, wounds and urethral catheters or for wetting dressings that come in contact with body tissues.

The flexible container is designed for use with nonvented irrigation sets. When used for irrigation via irrigation equipment, the administration set should be attached promptly. Unused portions should be discarded and a fresh container of appropriate size used for the start-up of each cycle or repeat procedure. For repeated irrigations of urethral catheters, a separate container should be used for each patient.

Do not administer unless solution is clear and container is undamaged. Discard unused portion.

Pregnancy Category C.

Animal reproduction studies have not been conducted with Lactated Ringer’s Irrigation. It is also not known whether it can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. It should be given to a pregnant woman only if clearly needed.

Pediatric Use:

The safety and effectiveness of Lactated Ringer’s Irrigation have not been established. Its limited use in pediatric patients has been inadequate to fully define proper dosage and limitations for use.

Adverse Reactions

Possible adverse effects arising from the irrigation of body cavities, tissues, or indwelling catheters and tubes are usually avoidable when proper procedures are followed. Displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. Excessive volume or pressure during irrigation of closed cavities may cause undue distension or disruption of tissues. Accidental contamination from careless technique may transmit infection.

Should any adverse reaction occur, discontinue the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

Ads by Google

Quality DSSC ElectrolytesIoLiTec supplies high quality DSSC electrolytes and custom formulationwww.iolitec.de

Serum Vial PackagingSerum Vials Seals Stoppers Crimpers Worldwide shipping - huge selectionwww.vgdusa.com

Transflux tmThe NEW STANDARD in contrast administration!www.prmedical.be

Overdosage

In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. (See WARNINGS, PRECAUTIONS and ADVERSE REACTIONS.)

Lactated Ringers Dosage and Administration

The dose is dependent upon the capacity or surface area of the structure to be irrigated and the nature of the procedure. When used as a vehicle for other drugs, the manufacturer’s recommendations should be followed.

Tear at notch and along dotted line and remove container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.

Drug Interactions

Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits. (See PRECAUTIONS.)

How is Lactated Ringers Supplied

Lactated Ringer’s Irrigation is supplied in single-dose 3000 mL flexible irrigation containers (NDC No. 0409–7828–08).

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing.

Revised: May, 2009

Printed in USA

EN-2136

Hospira, Inc., Lake Forest, IL 60045 USA

IM-0198

Dextrose in Lactated Ringer's Description

<script type="text/javascript" charset="ISO-8859-1" src="http://as.webmd.com/js.ng/Params.richmedia=yes&amp;transactionID=74678835&amp;tile=7467

8835&amp;site=2&amp;affiliate=38&amp;xpg=4046&amp;pos=121"></script>

Each 100 mL of 5% Dextrose in Lactated Ringer's Injection contains:Hydrous Dextrose USP 5 g; Sodium Chloride USP 0.6 gSodium Lactate 0.31 g; Potassium Chloride USP 0.03 gCalcium Chloride Dihydrate USP 0.02 gWater for Injection USP qs

pH adjusted with Hydrochloric Acid NFpH: 4.6 (4.0–6.0)Calories per liter: 170Calculated Osmolarity: 530 mOsmol/liter, hypertonic

Concentration of Electrolytes (mEq/liter): Sodium 130     Potassium 4Calcium 3      Chloride 112     Lactate (CH3CH(OH)COO−) 28

5% Dextrose in Lactated Ringer's Injection is sterile, nonpyrogenic and contains no bacteriostatic or antimicrobial agents. This product is intended for intravenous administration.

The formulas of the active ingredients are:

Ingredients Molecular Formula Molecular WeightSodium Chloride USP NaCl 58.44

Sodium Lactate CH3CH(OH)COONa 112.06Potassium Chloride USP KCl 74.55

Calcium Chloride Dihydrate USP CaCl2•2H2O 147.02

Hydrous Dextrose USP 198.17

The EXCEL Container is Latex-free, PVC-free, and DEHP-free.

The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

Addition of medication should be accomplished using complete aseptic technique.

The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.

Dextrose in Lactated Ringer's - Clinical Pharmacology

5% Dextrose in Lactated Ringer's Injection provides electrolytes and calories, and is a source of water for hydration. It is capable of inducing diuresis depending on the clinical condition of the patient. This solution also contains lactate which produces a metabolic alkalinizing effect.

Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid. Potassium, the principal cation of intracellular fluid, participates in carbohydrate utilization and protein synthesis, and is critical in the regulation of nerve conduction and muscle contraction, particularly in the heart.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. Calcium, an important cation, provides the framework of bones and teeth in the form of calcium phosphate and calcium carbonate. In the ionized form, calcium is essential for the functional mechanism of the clotting of blood, normal cardiac function, and regulation of neuromuscular irritability.

Sodium lactate is a racemic salt containing both the levo form, which is oxidized by the liver to bicarbonate, and the dextro form, which is converted to glycogen. Lactate is slowly metabolized to carbon dioxide and water, accepting one hydrogen ion and resulting in the formation of bicarbonate for the lactate consumed. These reactions depend on oxidative cellular activity.

Dextrose provides a source of calories. Dextrose is readily metabolized, may decrease losses of body protein and nitrogen, promotes glycogen deposition and decreases or prevents ketosis if sufficient doses are provided.

Ads by Google

Thailand Rehab $7,000 USDAsia's Best Drug & Alcohol Rehab. Effective, Affordable, World Class.alcoholrehab.com

Diabetic Diet & MealsFree Diabetic Recipes > Breakfast, Lunch - Snack - Dinner - Dessert.www.diabetesinfocenter.org

Gookinaid VitalyteElectrolyte Replacement GA. Free Shipping Offer.SummitHut.com

Indications and Usage for Dextrose in Lactated Ringer's

This solution is indicated for use in adults and pediatric patients as a source of electrolytes, calories and water for hydration.

Contraindications

This solution is contraindicated where the administration of sodium, potassium, calcium, chloride or lactate could be clinically detrimental.

Lactate administration is contraindicated in severe metabolic acidosis or alkalosis, and in severe liver disease or anoxic states which affect lactate metabolism.

Solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

Warnings

Solutions containing lactate are not for use in the treatment of lactic acidosis.

Solutions containing lactate should be used with great care in patients with metabolic or respiratory alkalosis, and in those conditions in which there is an increased level or an impaired utilization of lactate, such as severe hepatic insufficiency.

The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration.

Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there is sodium retention with edema.

Solutions containing potassium ions should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium ions retention is present.

In patients with diminished renal function, administration of solutions containing sodium or potassium ions may result in sodium or potassium retention.

Solutions containing calcium ions should not be administered through the same administration set as blood because of the likelihood of coagulation.

Precautions

General

This solution should be used with care in patients with hypervolemia, renal insufficiency, urinary tract obstruction, or impending or frank cardiac decompensation.

Extraordinary electrolytes losses such as may occur during protracted nasogastric suction, vomiting, diarrhea or gastrointestinal fistula drainage may necessitate additional electrolyte supplementation.

Additional essential electrolytes, minerals and vitamins should be supplied as needed.

Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotropin, or to other salt-retaining patients.

Care should be exercised in administering solutions containing sodium or potassium to patients with renal or cardiovascular insufficiency, with or without congestive heart failure, particularly if they are postoperative or elderly.

Solutions containing calcium should be used with caution in the presence of cardiac disease, particularly when accompanied by renal disease. Parenteral calcium should be administered with extreme caution to patients receiving digitalis preparations.

Solutions containing lactate should be used with caution. Excess administration may result in metabolic alkalosis.

The conversion of lactate to bicarbonate is markedly delayed in the presence of tissue anoxia and reduced capacity of the liver to metabolize lactate. This may occur under conditions such as metabolic acidosis associated with circulatory insufficiency, extracorporeal circulation, hypothermia, glycogen storage disease, liver dysfunction, respiratory alkalosis, shock or cardiac decompensation.

Solutions containing dextrose should be used with caution in patients with overt or known subclinical diabetes mellitus, or carbohydrate intolerance for any reason.

To minimize the risk of possible incompatibilities arising from mixing this solution with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration, and periodically during administration.

Do not use plastic container in series connection.

If administration is controlled by a pumping device, care must be taken to discontinue pumping action before the container runs dry or air embolism may result. If administration is not controlled by a pumping device, refrain from applying excessive pressure (>300mmHg) causing distortion to the container such as wringing or twisting. Such handling could result in breakage of the container.

This solution is intended for intravenous administration using sterile equipment. It is recommended that intravenous administration apparatus be replaced at least once every 24 hours.

Use only if solution is clear and container and seals are intact.

Laboratory Tests

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in this or an alternative solution.

Carcinogenesis, Mutagenesis, Impairment of Fertility

Studies with 5% Dextrose in Lactated Ringer's Injection have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.

Pregnancy

Teratogenic Effects

Pregnancy Category C

Animal reproduction studies have not been conducted with 5% Dextrose in Lactated Ringer's Injection. It is also not known whether 5% Dextrose in Lactated Ringer's Injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 5% Dextrose in Lactated Ringer's Injection should be given to a pregnant woman only if clearly needed.

Labor and Delivery

The effects of 5% Dextrose in Lactated Ringer's Injection on the duration of labor or delivery, on the possibility that forceps delivery or other intervention or resuscitation of the newborn will be necessary, and on the later growth, development, and functional maturation of the child are unknown.

As reported in the literature, 5% Dextrose in Lactated Ringer's Injection has been administered during labor and delivery. Caution should be exercised, and the fluid balance, glucose and

electrolyte concentrations, and acid-base balance, of both mother and fetus should be evaluated periodically or whenever warranted by the condition of the patient or fetus.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when 5% Dextrose in Lactated Ringer's Injection is administered to a nursing woman.

Pediatric Use

Safety and effectiveness of 5% Dextrose in Lactated Ringer's Injection in pediatric patients has not been established by adequate and well-controlled studies. However, as referenced in the medical literature, potassium chloride injection has been used to treat pediatric patients with potassium deficiency when oral replacement therapy is not feasible .

For patients receiving potassium supplement at greater than maintenance rates, frequent monitoring of serum potassium levels and serial EKGs are recommended.

Dextrose is safe and effective for the stated indications in pediatric patients (see INDICATIONS AND USAGE). As reported in the literature, the dosage selection and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia. Frequent monitoring of serum glucose concentrations is required when dextrose is prescribed to pediatric patients, particularly neonates and low birth weight infants.

In neonates or in very small infants even small volumes of fluid may affect fluid and electrolyte balance. Care must be exercised in treatment of neonates, especially pre-term neonates, whose renal function may be immature and whose ability to excrete fluid and solute loads may be limited. Fluid intake, urine output, and serum glucose and electrolytes should be monitored closely.

See WARNINGS and DOSAGE AND ADMINISTRATION.

Geriatric Use

Clinical studies of 5% Dextrose in Lactated Ringer's Injection did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients.

In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.

See WARNINGS.

Adverse Reactions

Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.

Too rapid infusion of hypertonic solutions may cause local pain and venous irritation. Rate of administration should be adjusted according to tolerance. Use of the largest peripheral vein and a small bore needle is recommended. (See DOSAGE AND ADMINISTRATION.)

Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.

Hypernatremia may be associated with edema and exacerbation of congestive heart failure due to the retention of water, resulting in an expanded extracellular fluid volume.

Reactions reported with the use of potassium-containing solutions include nausea, vomiting, abdominal pain and diarrhea. The signs and symptoms of potassium intoxication include paresthesias of the extremities, areflexia, muscular or respiratory paralysis, mental confusion, weakness, hypotension, cardiac arrhythmias, heart block, electrocardiographic abnormalities and cardiac arrest. Potassium deficits result in disruption of neuromuscular function, and intestinal ileus and dilatation.

If infused in large amounts, chloride ions may cause a loss of bicarbonate ions, resulting in an acidifying effect.

Abnormally high plasma levels of calcium can result in depression, amnesia, headaches, drowsiness, disorientation, syncope, hallucinations, hypotonia of both skeletal and smooth muscles, dysphagia, arrhythmias and coma. Calcium deficits can result in neuromuscular hyperexcitability, including cramps and convulsions.

Although the metabolism of lactate to bicarbonate is a relatively slow process, aggressive administration of sodium lactate may result in metabolic alkalosis. Careful monitoring of blood acid-base balance is essential during the administration of sodium lactate.

The physician should also be alert to the possibility of adverse reactions to drug additives. Prescribing information for drug additives to be administered in this manner should be consulted.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

Ads by Google

Apelon, Inc.The RxNorm and NDF-RT data standard experts.www.Apelon.com

Ask a Dr: Side EffectsA Doctor Will Answer You Now! Side Effects Answers Today: 87.Health.JustAnswer.com/Side-Effects

Private Drug RehabFirst Class treatment Private Drug Rehabilitation Programwww.LuxuryTreatment.com/Private

Overdosage

In the event of a fluid or solute overload during parenteral therapy, reevaluate the patient's condition and institute appropriate corrective treatment.

Dextrose in Lactated Ringer's Dosage and Administration

This solution is for intravenous use only.

Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy.

When a hypertonic solution is to be administered peripherally, it should be slowly infused through a small bore needle, placed well within the lumen of a large vein to minimize venous irritation. Carefully avoid infiltration.

Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient.

The presence of calcium ions in this solution should be considered when phosphate is present in additive solutions, in order to avoid precipitation.

Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Pediatric Use

There is no specific pediatric dose. The dose is dependent on weight, clinical condition and laboratory results. See WARNINGS and PRECAUTIONS.

How is Dextrose in Lactated Ringer's Supplied

5% Dextrose in Lactated Ringer's Injection is supplied sterile and nonpyrogenic in EXCEL® Containers. The 1000 mL containers are packaged 12 per case and the 500 mL containers are packaged 24 per case.

NDC Cat. No. Size5% Dextrose in Lactated Ringer's Injection

(Canada DIN 01931652)0264-7751-00 L7510 1000 mL0264-7751-10 L7511 500 mL

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.

Rx only

Revised: December 2009EXCEL® is a registered trademark of B. Braun Medical Inc.

Directions for Use of EXCEL® Container

Caution: Do not use plastic container in series connection.

To Open

Tear overwrap down at notch and remove solution container. Check for minute leaks by squeezing solution container firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below before preparing for administration.

NOTE: Before use, perform the following checks:

Inspect each container. Read the label. Ensure solution is the one ordered and is within the expiration date.

Invert container and carefully inspect the solution in good light for cloudiness, haze, or

particulate matter. Any container which is suspect should not be used.

Use only if solution is clear and container and seals are intact.

Preparation for Administration

1. Remove plastic protector from sterile set port at bottom of container.2. Attach administration set. Refer to complete directions accompanying set.

To Add Medication

Warning: Some additives may be incompatible.

To Add Medication Before Solution Administration

1. Prepare medication site.2. Using syringe with 18–22 gauge needle, puncture medication port and inner diaphragm and

inject.3. Squeeze and tap ports while ports are upright and mix solution and medication thoroughly.

To Add Medication During Solution Administration

1. Close clamp on the set.2. Prepare medication site.3. Using syringe with 18–22 gauge needle of appropriate length (at least 5/8 inch), puncture

resealable medication port and inner diaphragm and inject.4. Remove container from IV pole and/or turn to an upright position.5. Evacuate both ports by tapping and squeezing them while container is in the upright position.6. Mix solution and medication thoroughly.7. Return container to in use position and continue administration.

B. Braun Medical Inc.Irvine, CA 92614-5895 USAMade in USA

In Canada, distributed by:B. Braun Medical Inc.Scarborough, Ontario M1H 2W4

Y36-002-713

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

5% Dextrose inLactated Ringer's Injection

REF L7510NDC 0264-7751-00DIN 01931652

1000 mLEXCEL® CONTAINER

Each 100 mL contains:Hydrous Dextrose USP 5 gSodium Chloride USP 0.6 gSodium Lactate 0.31 gPotassium Chloride USP 0.03 gCalcium Chloride•2H2O USP 0.02 gWater for Injection USP qspH adjusted with HCl NF

pH: 4.6 (4.0-6.0)Calc. Osmolarity: 530 mOsmol/liter, hypertonic

Electrolytes (mEq/liter):   Na+ 130    K+ 4Ca++ 3    CI– 112    Lactate 28

Sterile, nonpyrogenic. Single dose container.

Do not use in series connection.For intravenous use only. Use only if solution is clear andcontainer and seals are intact.

Warnings: NOT FOR USE IN THE TREATMENT OFLACTIC ACIDOSIS. Do Not Administer SimultaneouslyWith Blood. Some additives may be incompatible.Consult with pharmacist. When introducing additives,use aseptic techniques. Mix thoroughly. Do not store.

Recommended Storage:Room temperature (25°C). Avoid excessive heat. Protectfrom freezing. See Package Insert.

Rx only

EXCEL is a registered trademarkof B. Braun Medical Inc.

7OTHER

B. Braun Medical Inc.Irvine, CA 92614-5895 USA1-800-227-2862www.bbraun.comMade in USA

In Canada, distributed by:B. Braun Medical Inc.Scarborough, Ontario M1H 2W4

Y94-003-038LD-141-2

Do not remove overwrap until ready for use. Afterremoving the overwrap, check for minute leaks bysqueezing container firmly. If leaks are found, discardsolution as sterility may be impaired.

PRINCIPAL DISPLAY PANEL - 500 mL Container Label

5% Dextrose inLactated Ringer's Injection

REF L7511NDC 0264-7751-10DIN 01931652

500 mLEXCEL® CONTAINER

Each 100 mL contains:Hydrous Dextrose USP 5 g; Sodium Chloride USP 0.6 gSodium Lactate 0.31 g; Potassium Chloride USP 0.03 gCalcium Chloride•2H2O USP 0.02 g; Water for Injection USP qspH adjusted with HCl NF

pH: 4.6 (4.0-6.0); Calc. Osmolarity: 530 mOsmol/liter, hypertonic

Electrolytes (mEq/liter):   Na+ 130     K+ 4     Ca++ 3Cl– 112     Lactate 28

Sterile, nonpyrogenic. Single dose container.

Do not use in series connection. For intravenous use only.Use only if solution is clear and container and seals are intact.

WARNINGS: NOT FOR USE IN THE TREATMENT OF LACTIC ACIDOSIS.Do Not Administer Simultaneously With Blood. Some additives maybe incompatible. Consult with pharmacist. When introducingadditives, use aseptic techniques. Mix thoroughly. Do not store.

Recommended Storage: Room temperature (25°C).Avoid excessive heat. Protect from freezing. See Package Insert.

Rx only

EXCEL is a registered trademark of B. Braun Medical Inc.

7OTHER

B. Braun Medical Inc.Irvine, CA 92614-5895 USA

1-800-227-2862www.bbraun.com Made in USA

In Canada, distributed by:B. Braun Medical Inc.Scarborough, Ontario M1H 2W4

Y94-003-039LD-140-2

Do not remove overwrap until ready for use. After removing the overwrap,check for minute leaks by squeezing container firmly. If leaks are found,discard solution as sterility may be impaired.

DEXTROSE IN LACTATED RINGERS dextrose, sodium chloride, sodium lactate, potassium chloride, and calcium chloride solution

Product Information

Product Type HUMAN PRESCRIPTION DRUG

NDC Product Code (Source) 0264-7751

Route of Administration INTRAVENOUS DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength

DEXTROSE (DEXTROSE) DEXTROSE 5 g in 100 mL

SODIUM CHLORIDE (SODIUM CATION) SODIUM CHLORIDE 0.6 g in 100 mL

SODIUM LACTATE (SODIUM CATION) SODIUM LACTATE 0.31 g in 100 mL

POTASSIUM CHLORIDE (POTASSIUM CATION) POTASSIUM CHLORIDE 0.03 g in 100 mL

CALCIUM CHLORIDE (CALCIUM CATION) CALCIUM CHLORIDE 0.02 g in 100 mL

Inactive Ingredients

Ingredient Name Strength

WATER

Product Characteristics

Color Score

Shape Size

Flavor Imprint Code

Contains

Packaging

# NDC Package Description Multilevel Packaging

1 0264-7751-00 12 CONTAINER In 1 CASE contains a CONTAINER

1 1000 mL In 1 CONTAINER This package is contained within the CASE (0264-7751-00)

2 0264-7751-10 24 CONTAINER In 1 CASE contains a CONTAINER

2 500 mL In 1 CONTAINER This package is contained within the CASE (0264-7751-10)

Marketing Information

Marketing Category

Application Number or Monograph Citation

Marketing Start Date

Marketing End Date

NDA NDA019634 02/24/1988

Labeler - B. Braun Medical Inc. (002397347)

Establishment

Name Address ID/FEI Operations

B Braun Medical Inc 037425308 MANUFACTURERevised: 02/2011B. Braun Medical Inc.

Ads by GoogleOrthomolecular

Alternative Mental Health Treating the mind via the body.www.earthhouse.orgVideo Chat For Free

Video Chat & Connect With Friends On Facebook. Sign Up Today!www.Facebook.com

Lactated Ringers sodium chloride, sodium lactate, potassium chloride, and calcium chloride irrigant

Product Information

Product TypeHUMAN PRESCRIPTION DRUG

NDC Product Code (Source)

0409-7828

Route of Administration IRRIGATION DEA Schedule     

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength

SODIUM CHLORIDE (SODIUM CATION and CHLORIDE ION)

SODIUM CHLORIDE

600 mg in 100 mL

SODIUM LACTATE (SODIUM CATION)SODIUM LACTATE

310 mg in 100 mL

POTASSIUM CHLORIDE (POTASSIUM CATION and CHLORIDE ION)

POTASSIUM CHLORIDE

30 mg in 100 mL

CALCIUM CHLORIDE (CALCIUM CATION and CHLORIDE ION)

CALCIUM CHLORIDE

20 mg in 100 mL

Inactive Ingredients

Ingredient Name Strength

WATER  

SODIUM HYDROXIDE  

HYDROCHLORIC ACID  

Product Characteristics

Color      Score     

Shape Size

Flavor Imprint Code

Contains     

Packaging

# NDC Package Description Multilevel Packaging

10409-7828-08

4 CONTAINER In 1 CASE

contains a CONTAINER

11 BAG In 1 CONTAINER

This package is contained within the CASE (0409-7828-08) and contains a BAG

1 3000 mL In 1 BAGThis package is contained within a CONTAINER and a CASE (0409-7828-08)

Marketing Information

Marketing Category

Application Number or Monograph Citation

Marketing Start Date

Marketing End Date

ANDA ANDA019416 01/24/2011

Labeler - Hospira, Inc. (141588017)Revised: 01/2011Hospira, Inc.Ads by GoogleQuality DSSC ElectrolytesIoLiTec supplies high quality DSSC electrolytes and custom formulationwww.iolitec.deSerum Vial PackagingSerum Vials Seals Stoppers Crimpers Worldwide shipping - huge selectionwww.vgdusa.com